Immutable evidence record · ticker
Ultragenyx Pharmaceutical Inc. (R2AR34)
Published as observed on 1 August 2026 at 09:17 BST.
Ultragenyx Pharmaceutical Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.
- As of
- 1 Aug 2026, 09:17
- Scope
- company and instrument
- Evidence
- 8 items
- Independent sources
- 7
- Country
- Brazil
- Sector
- Healthcare
- Previous read
- 45.000
- Change
- 2.000
Verification
Evidence links
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Ultragenyx Pharmaceutical Inc. (R2AR34), 2026-08-01, https://sharemaestro.com/evidence/597c5887-858b-4e6a-afb2-bdfa15dfb22e/
Record checksum b576912aac1346f9f067fe7ccbc3c9e49a22118b503388a4806e413206ee42ef
